Clinicopathologic and prognostic characteristics of tumor budding‐like in giant cell tumor of bone
Cancer · 2024
DOI: 10.1002/cncr.35551 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Cancer, 2024. Verfasst von Bo-Wen Zheng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Musculoskeletal Tumor Center, Peking University People's Hospital, Peking University, Beijing, China. Hauptthemen laut MEDLINE: Giant Cell Tumor of Bone, Bone Neoplasms, Lymphocytes, Tumor-Infiltrating, Denosumab. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: National Natural Science Foundation of China, China Scholarship Council, Xiaohe Technology Talent Project of Hengyang city.
Abstract (Originalsprache)
Background
Currently, tumor budding (TB) is defined as an important factor for a poor prognosis in various types of cancers. The authors identified a significant presence of TB‐like structures at the tumor invasive front in giant cell tumor of bone (GCTB), which may have the same biologic function as TB. The objective of this report was to describe the distribution of TB in GCTB and investigate its correlation with clinicopathologic characteristics, the immune microenvironment, survival prognosis, and response to denosumab treatment.
Methods
This multicenter cohort study included 426 patients with GCTB who received treatment between 2012 and 2021 at four centers. Two independent pathologists performed visual assessments of TBL structures in hematoxylin‐and‐eosin–stained tumor sections. Immunohistochemistry was used to evaluate tumor‐infiltrating lymphocyte subtypes (CD3‐positive, CD4‐positive, CD8‐positive, CD20‐positive, programmed cell death protein‐1–positive, programmed cell death‐ligand 1positive, and FoxP3‐positive) as well as Ki‐67 expression levels in 426 tissue samples. These parameters were then analyzed for associations with patient outcomes (local recurrence‐free survival [LRFS] and overall survival [OS]), clinicopathologic characteristics, and response to denosumab treatment.
Results
High‐grade TB was associated with poorer LRFS and OS in both patient groups. In addition, TB was correlated with various clinicopathologic features, tumor‐infiltrating lymphocyte expression, and response to denosumab treatment. TB outperformed the traditional Enneking and Campanacci staging systems in predicting patient LRFS and OS.
Conclusions
The current data support the assessment of TBL structures as a reliable prognostic tool in GCTB, potentially aiding in the development of personalized treatment strategies for patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Musculoskeletal Tumor Center, Peking University People's Hospital, Peking University, Beijing, China.
- Department of Orthopedic Surgery, General Hospital of the Central Theater Command, Wuhan, China.
- Arthritis Clinical and Research Center, Peking University People's Hospital, Peking University, Beijing, China.
- Department of Ophthalmology, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
- Department of Orthopedic Surgery, Xiangya Hospital, Central South University, Changsha, China.
- Department of Spine Surgery, The First Affiliated Hospital, University of South China, Hengyang, China.
ORCID-Profile: Bo-Wen Zheng, Zhen Yang
Förderung
- National Natural Science Foundation of China
- China Scholarship Council
- Xiaohe Technology Talent Project of Hengyang city
Zitieren
APA
Zheng, B. W., Zheng, B. Y., Yang, Z., Niu, H. Q., Zhu, G. Q., Zou, M. X., Liu, F. S., & Xia, C. (2024). Clinicopathologic and prognostic characteristics of tumor budding‐like in giant cell tumor of bone. Cancer. https://doi.org/10.1002/cncr.35551
Vancouver
Zheng BW, Zheng BY, Yang Z, Niu HQ, Zhu GQ, Zou MX, et al. Clinicopathologic and prognostic characteristics of tumor budding‐like in giant cell tumor of bone. Cancer. 2024. doi:10.1002/cncr.35551
BibTeX
@article{Zheng2024,
author = {Zheng, Bo-Wen and Zheng, Bo-Yv and Yang, Zhen and Niu, Hua-Qing and Zhu, Guo-Qiang and Zou, Ming-Xiang and Liu, Fu-Sheng and Xia, Chao},
title = {Clinicopathologic and prognostic characteristics of tumor budding‐like in giant cell tumor of bone},
journal = {Cancer},
year = {2024},
doi = {10.1002/cncr.35551}
}
EUVIMED